Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Roberto Carlos V. Silva"'
Autor:
Giuliana X. Medeiros, Greyce Luri Sasahara, Jhosiene Y. Magawa, João Paulo S. Nunes, Fernanda R. Bruno, Andreia C. Kuramoto, Rafael R. Almeida, Marcelo A. Ferreira, Guilherme P. Scagion, Érika D. Candido, Fabyano B. Leal, Danielle B. L. Oliveira, Edison L. Durigon, Roberto Carlos V. Silva, Daniela S. Rosa, Silvia B. Boscardin, Verônica Coelho, Jorge Kalil, Keity S. Santos, Edecio Cunha-Neto
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
CoronaVac is an inactivated SARS-CoV-2 vaccine that has been rolled out in several low and middle-income countries including Brazil, where it was the mainstay of the first wave of immunization of healthcare workers and the elderly population. We aime
Externí odkaz:
https://doaj.org/article/d4a9d3442d5b42f0ad02ccd031cbe903
Autor:
Keity Souza Santos, G.X. Medeiros, Silvia Beatriz Boscardin, Jorge Kalil, Andréia Kuramoto, Daniela Santoro Rosa, Edecio Cunha-Neto, G.L. Sasahara, Jps Nunes, Fabyano Bruno Leal, Marcelo Alves Ferreira, Roberto Carlos V Silva, Edison Luiz Durigon, Verônica Coelho, Guilherme Pereira Scagion, F.R. Bruno, Danielle Bruna Leal Oliveira, Jhosiene Y. Magawa, Erika Donizette Candido, Rafael Ribeiro Almeida
BackgroundCoronaVac is an inactivated SARS-CoV-2 vaccine that has been rolled out in several low and middle-income countries including Brazil, where it was the mainstay of the first wave of immunization of health care workers and the elderly populati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::267c4087673c7e99e481828fd5db6f0f
https://doi.org/10.1101/2021.08.16.21262069
https://doi.org/10.1101/2021.08.16.21262069
Autor:
Silvia Beatriz Boscardin, Jamille R Oliveira, Gabriele Gadermaier, Edison Luiz Durigon, Daniela Santoro Rosa, Jhosiene Y. Magawa, Verônica Coelho, Rafael Rg Machado, Edecio Cunha-Neto, Alysson H. Urbanski, Isabela P Daher, Roberto Carlos V Silva, Deborah Schechtman, Keity Souza Santos, Gabriela Jh Schmitz, Helder I. Nakaya, Jorge Kalil
Recent SARS-CoV-2 variants pose important concerns due to their higher transmissibility (1) and escape (2) from previous infections or vaccine-induced neutralizing antibodies (nAb). The receptor binding domain (RBD) of the Spike protein is a major nA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb29105acf70074cb0be790dca55ce9f
https://doi.org/10.1101/2021.03.11.21253399
https://doi.org/10.1101/2021.03.11.21253399
Autor:
Andreia Costa, C. Fernandes, Pedro Soares, Cláudia Caeiro, C. Borges, Carlota Lemos, Roberto Carlos V Silva, C. Sarmento
BackgroundPatients with high-grade glioma (HGG) are at increased risk of venous thromboembolism (VTE), throughout the course of disease. Prophylactic anticoagulation is not established among patients with HGG, outside of perioperative context, due to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45086b825821b3a129ace94541f1a826
https://doi.org/10.1101/2020.01.17.20017475
https://doi.org/10.1101/2020.01.17.20017475
Autor:
Andreia Costa, C. Fernandes, C. Lemos, Isabelle Katherinne Fernandes Costa, J. Simões, C. Sarmento, C. Borges, Roberto Carlos V Silva, J. Reis, Cláudia Caeiro, B. Carvalho, Paula Soares
Publikováno v:
Annals of Oncology. 30:v152-v153
Background Patients with high-grade glioma (HGG) are at increased risk of venous thromboembolism (VTE), throughout the course of disease. Prophylactic anticoagulation is not established outside of perioperative context, due to potential for intracran